Matthew Paul Del Giudice insider trades

Open-market stock purchases and sales by Matthew Paul Del Giudice, Director at Mira Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 25, 2024.

Recent trades

DateStockTradeValue
Jun 12, 2026MIRA Mira Pharmaceuticals, IncBought (not open market)—
May 21, 2026TELO Telomir Pharmaceuticals, IncBought (not open market)$32.5K
May 21, 2026TELO Telomir Pharmaceuticals, IncSold (not open market)$126K

Companies traded

  • MIRA Mira Pharmaceuticals, Inc: other filings, last Jun 12, 2026
  • TELO Telomir Pharmaceuticals, Inc: other filings, last May 21, 2026

Get free alerts when Matthew Paul Del Giudice files a new trade →